Next-generation sequencing allows the characterization of the adaptive immune receptor repertoire (AIRR) in exquisite detail. These large-scale AIRR-seq data sets have rapidly become critical to vaccine development, understanding the immune response in autoimmune and infectious disease, and monitoring novel therapeutics against cancer. However, at present there is no easy way to compare these AIRR-seq data sets across studies and institutions. The ability to combine and compare information for different disease conditions will greatly enhance the value of AIRR-seq data for improving biomedical research and patient care. The iReceptor Data Integration Platform (gateway.ireceptor.org) provides one implementation of the AIRR Data Commons envisioned by the AIRR Community (airr-community.org), an initiative that is developing protocols to facilitate sharing and comparing AIRR-seq data. The iReceptor Scientific Gateway links distributed (federated) AIRR-seq repositories, allowing sequence searches or metadata queries across multiple studies at multiple institutions, returning sets of sequences fulfilling specific criteria. We present a review of the development of iReceptor, and how it fits in with the general trend toward sharing genomic and health data, and the development of standards for describing and reporting AIRR-seq data. Researchers interested in integrating their repositories of AIRR-seq data into the iReceptor Platform are invited to contact support@ireceptor.org.
| INTRODUC TI ON
The integration of large-scale genomic data with extensive health data is revolutionizing biomedical research and holds great potential for improving patient care. However, our ability to share these large-scale data across studies and institutions is limited. Facilitating sharing these data across studies will greatly increase sample sizes, strengthening our statistical inferences, and will be vitally important to searching for the patterns that underlie personalized medicine approaches, as we try to develop specific therapies based on an individual's genotype, personal exposure history, and clinical response.
Goodhand
1 has argued that one efficient way to facilitate sharing
| AIRR-S EQ DATA : CHALLENG E S AND COMMUNIT Y RE S P ONS E
The adaptive immune system has evolved a unique molecular diversification mechanism designed to produce a highly diverse set of antigen receptors. This diverse set of antibody/B-cell and T-cell receptors is necessary to recognize and remove the vast and everchanging array of pathogens that an individual will encounter over a lifetime, while differentiating these pathogens from self. This unique genetic mechanism, and the sheer immensity of the Antibody/B-cell and T-cell response, presents challenges for producing, storing, sharing, and analyzing these data.
The unique mechanism involves recombining sets of V-, D-, and J-genes that encode these receptors, along with the introduction of variability at the joints between these recombined gene segments. 3 As a result of this recombination process, the random pairing of Ig heavy and light B-cell receptor (BCR) chains (or paired T-cell receptor [TCR] chains), and somatic hypermutation (which is unique to BCRs 4 ), the diversity of the AIRR greatly exceeds the coding capacity of the genome. For example, it is estimated that humans express a hundred million or more unique B-cell and T-cell receptors. [5] [6] [7] It was in 2009 that NGS approaches were first used to characterize this AIRR in exquisite detail, producing 10 6 or 10 7 sequences, for multiple time points, per sample (AIRR-seq data). These data sets have grown quickly in size and number, and exist in multiple repositories across laboratories, studies, and institutions.
Not only do these AIRR-seq data sets often comprise many millions of sequences per sample but they also require extensive analysis or "processing" after sequencing and prior to being interpreted.
Such analyses are performed in a sequential series of steps or "data analysis pipelines" that vary between investigators. A typical data analysis pipeline begins with raw reads (often in the form of FASTQ sequences) produced by NGS sequencing technology. Low-quality sequences are removed from these "base-call" data, which is often accomplished with arbitrary cut-offs. "Paired-end" reads are merged into a single sequence to obtain "full reads", often with seemingly arbitrary rules for excluding short sequences and imprecise merges.
Different algorithms are then used for assigning Variable (V-), Diversity (D-), and Joining (J-) gene segment usage and for assigning somatic mutations in the case of antibody/B-cell sequences (reviewed in 8, 9). Furthermore, several very different approaches can be used to identify and characterize clonal lineages (each clonal lineage being the set of descendants of a given "ancestral" B-or Tcell produced during the development of an individual). For example, clones can be recognized on the basis of shared V-and J-gene usage, and CDR3 length and diversity (CDR3 is a specific region in an immune receptor, often important in binding to pathogens and other molecules). 10 Alternatively, phylogenetic, hierarchical clustering or probabilistic approaches can be used to assign sequences to clones. [11] [12] [13] All this information describing the processing of the sequences, and the results of this processing, must be stored along with the sequence data.
In summary, these AIRR-seq data require unique annotation tools, specialized database models for storing annotated data, and idiosyncratic ways of defining and tracking clonal relationships, in addition to requiring massive storage. As these data sets grow in size and number, they also grow in importance for research in infectious diseases and vaccine development, development of therapies for autoimmune diseases, and in novel cancer immunotherapy approaches, among other applications (see Section 2.1). These challenges have not been fully addressed, but in Section 2.2 we describe an initiative to adopt community protocols and standards to facilitate sharing and integrating these immense AIRR-seq data sets, and starting in Section 3 we describe a federated database approach to integrating these data, as implemented in the iReceptor Data Integration Platform.
| Recent applications of AIRR-seq data
Since 2009, AIRR-seq data have been applied to a broad range of biomedical questions, including autoimmune diseases, 14 infectious diseases, and vaccine development, particularly HIV 15, 16 and flu, 17 and cancer immunotherapy. 18, 19 Here, we review some of the latest applications of this type of data, emphasizing studies that would benefit from performing analyses across federated repositories covering many studies, laboratories, and institutions.
One of the latest breakthroughs based on these highly diverse AIRR-seq data is a novel way to diagnose infectious diseases. As a proof of principle, Emerson et al 20 showed that NGS sequencing of the T-cell receptor (TCRβ) repertoire could be used to distinguish individuals who were infected with CMV from those who were not. They employed a training set of 666 subjects and a validation cohort of 120 subjects infected with CMV, all compared to 640 CMV-negative subjects. Their method depended on identifying more than 164 CMVassociated TCRβ sequences in a majority of individuals ("public" T-cell receptor sequences associated with CMV infection). Once these were identified, then by sequencing approximately 200K sequences per individual, and comparing the frequency of CMV-associated vs private TCRβ sequences in each individual, they were able to correctly identify CMV+ individuals with 93% accuracy. This demonstration that the TCRβ repertoire is shaped by exposure, and thus can be used to identify whether an individual is infected with a specific pathogen, will become increasingly important as a diagnostic tool for diseases more difficult to identify. However, the sample sizes needed to differentiate signal from noise for this application to other diseases will necessitate integrating large data sets across multiple institutions and laboratories.
AIRR-seq data are also being used in multiple ways to investigate the causes and possible treatments of autoimmune diseases. One recent example is a study of celiac disease by Gunnarsen et al 21 , showing how these data can be used to answer long-standing questions in autoimmunity. Celiac disease (CD) occurs primarily in individuals with particular alleles at the HLA loci, a set of genes that are often associated with infectious and autoimmune disease susceptibility.
Individuals with these susceptibility alleles for CD at the HLA loci are characterized by a T-cell response against very specific binding motifs in the gluten molecule. Analysis of T-cell receptor repertoires sequenced from the blood of 9 celiac disease patients after gluten challenge identified 536 unique T-cell receptor clonotypes, which were further studied for the specific molecular interactions promoting the disease. Based on these results, the authors were able to show how these molecular interactions recruited a pathogenic TCR repertoire in celiac disease, leading to one explanation why TCRbiased repertoires are so frequently seen in HLA-associated diseases. Examining these patterns in more autoimmune diseases, using larger sample sizes, could determine the generality of this approach.
One of the most important applications of AIRR-seq data is to the field of anti-cancer immunotherapy. Malignant cancers are characterized by multiple mutations compared to normal tissue, and thus the adaptive immune system should recognize malignant tissue and remove it. However, many tumors release checkpoint molecules that suppress this immune response, thus allowing tumors to grow uncontrollably. Immunotherapy has become a key weapon against cancer, through the development of "anti-checkpoint therapies" that suppress these checkpoint molecules, thus releasing the immune system against the malignant tumors. This approach has seen some amazing successes; for example, anti-checkpoint immunotherapy has raised the 3-year overall survival for advanced melanoma from 12% before 2010 to approximately 60% in 2017. 22 However, in other types of cancer, as few as 10% of patients treated respond to the immunotherapy, leading to an intense search for biomarkers that could differentiate responders from non-responders (one of the priority questions in personalized medicine). Many studies are examining whether there are AIRR-seq data signals that can make this determination, and this effort is one of the main drivers of the explosion of studies sequencing B-cell and T-cell repertoires in multiple cancers.
One recent example of using TCR repertoires to monitor and predict response to anti-checkpoint therapy is provided by Snyder et al 23 , who studied urothelial cancer patients treated with atezolizumab. These researchers concentrated on the clonality of the TCRβ repertoire, the set of sequences making up one of the two chains in a T-cell receptor.
High clonality would mean a repertoire was less diverse, in that many of the sequences in the repertoire would consist of only a few dominant clones. They observed that high pretreatment peripheral blood TCRβ clonality was strongly associated with poor clinical outcomes; this suggests that clonality could be a biomarker, possibly capable of stratifying patients into potential good and poor responders in personalized cancer immunotherapy. As emphasized by the authors, 23 the sample sizes in this study were small; only 19 individuals were available who had been treated with the monoclonal antibody. The authors state: "The patients under study were treated at a single institution and represent a small subset of the overall study, limiting statistical power." This clearly shows the necessity of the iReceptor approach, which would allow these researchers to easily compare their results and patterns with other individuals being treated with anti-checkpoint therapies.
As exciting as the anti-checkpoint therapy approach is, there is at least one challenge to its general application, and that is that these anti-checkpoint drugs may also induce inflammatory responses and toxicities termed immune-related adverse events (irAEs) in a signif- In the Oh et al study, irAE patients exhibited a greater diversity of sequences in the T-cell repertoire. This points out that it is essential that the results of such studies be compared across diseases, treatments, and institutions, so that we can look for consistent biomarker patterns in the T-cell (and B-cell) repertoires, predicting clinical outcomes such as immune adverse effects.
| The AIRR Community
The AIRR Community (airr-community. At the 2017 AIRR Community Meeting, these working groups were expanded, with the following groups established and actively meeting on a regular basis:
• Minimal standards-developing a set of metadata standards for the publication and sharing of AIRR-seq datasets
• Common repository-establishing the requirements for repositories that will store AIRR-seq data-an AIRR Data Commons 
| IRECEP TOR-TOWARD AN AIRR-S EQ DATA COMMONS

| What is iReceptor?
iReceptor is a distributed data management system and scientific gateway for mining "Next Generation" sequence data from immune responses. The main goal of iReceptor is to provide a web-based platform that will lower the barrier to immune genetics researchers who need to federate large, distributed, AIRR-seq data repositories to answer complex questions about the immune response.
At the most basic level, iReceptor consists of two key components: a distributed network of data repositories (an AIRR-seq data commons) and a web-based Scientific Gateway that allows researchers to discover, federate, explore, and analyze AIRR-seq data of interest across that network of data repositories (Figure 1 ).
| Why an AIRR data commons and why be FAIR?
Both 29 Today, it is widely accepted that for research outputs to be truly globally useful, it is necessary for data to be Findable, Accessible, Interoperable, and Reusable (FAIR).
The importance of data repositories that are collectively owned and managed by a community of users (a data commons), and in Although the technologies with which groups build data commons continue to evolve, and therefore different groups and communities take different approaches to implementing data commons, four basic structural models have emerged, varying in their level of centralization. 33 These structural models are as follows:
• Fully centralized, where all data are integrated into a single repos- Genome Consortium (ICGC) and its ICGC "franchise" data sets. 36 This category encompasses iReceptor and the iReceptor Data Commons
• Fully distributed, where repositories are distributed, not technically integrated, but share a common legal or policy framework
• Non-commons, where repositories lack technical and legal interoperability and at most, might share a common index
| Why distributed data repositories for AIRR-seq data?
Given the uptake, and the success, of projects that use the intermediate distributed data model (as discussed above), in particular by organizations such as GA4GH and the ICGC, iReceptor has chosen to use a distributed data model for its AIRR-seq data commons. A distributed data model, although difficult to support, is we believe critical to the success of research in this area for two main reasons.
Firstly, NGS has caused an explosion in the data available to laboratories that are carrying out research on AIRR-seq data. To answer complex research questions, these laboratories need to collaborate in a variety of ways. Although large-scale repositories for sequence data exist, it is our belief that it is not practical to provide a central repository at the scale that will be required by the AIRR research community. We know this from our own experience where we have seen the challenges of trying to effectively query even a small laboratory's data. We also know that this is only the first challenge, as a central repository would need to provide similar resources for hundreds of groups nationally and internationally. Alternatively, a distributed data model, although it does not exclude some large, public repositories in the network, means that it is possible for each laboratory to store and manage its own data if they so choose. This provides a mechanism for groups to "scale-up" individual repositories to handle large amounts of data while at the same time providing the ability for the community to "scale-out" by federating tens, if not hundreds of repositories. If interfaces to these repositories can be defined consistently and adhering to community standards, then tools can access the distributed repositories to perform complex analyses which in turn allow complex research questions (through queries that federate data from distributed repositories) to be answered.
Secondly, AIRR-seq data are mostly patient data, and therefore need to be treated with confidentiality and security. Data use typically goes through institutional ethics boards, requiring data stewards at given institutions to be confident that data are treated securely. A distributed data model enables a data steward to store, monitor, and share data as appropriate to the study's ethics and sharing agreements while at the same time having explicit and direct control over who has access to those data.
The goal of iReceptor is to hide the technical complexities of the above problems, while at the same time empowering AIRR-seq researchers to perform very sophisticated (and in many cases, computationally expensive) analyses on federated data from multiple, distributed repositories.
| The past-iReceptor v1.0
The evolution of iReceptor followed a very similar timeline to that of To create an abstraction layer between the data repository implementation (the actual database technology used) and the tools that would utilize and query those repositories, iReceptor v1.0 also implemented a web-based application programming interface (REST API) for querying and returning data from these AIRR-seq data repositories. iReceptor v1.0 also created an iReceptor Repository service that translated queries/requests received through the REST API into queries on the actual repository that return the correct data.
Assuming all data repositories in the network have iReceptor compliant data in them, the combination of the iReceptor API and the iReceptor Repository Service provides a mechanism for external tools to query the network of AIRR-seq repositories using a single, consistent API, federate the results of those queries, and perform complex analyses on those federated data to answer complex research questions.
The iReceptor REST API defines a set of queries, and as a result, each iReceptor Repository Service must implement those queries.
In iReceptor v1.0, three query levels were supported: queries at the metadata summary level (eg, return summaries of the types of data your repository contains), the biological sample level (eg, return all samples that satisfy certain criteria, such as all data that are from female subjects associated with cancer studies), and the annotated sequence level (eg, return all sequences that contain the annotated V-gene allele IGLV3-1*01). Each query type is implemented through a web service through a web query of the form:
• https://repository.mine.org/metadata
• https://repository.mine.org/samples?sex=F&disease_state=
Cancer
The iReceptor Scientific Gateway provides a web-based graphical user interface (GUI) that allows researchers to pose queries of this form and makes use of the iReceptor REST API to query and federate data from the iReceptor repository network. The iReceptor Gateway then either presents the user with summary statistics of federated results of the query, allows the user to download the federated data, or pass the data to an analysis application for federated data analysis.
One of the key goals of iReceptor is to make it easy for research- ical samples and their relevant study and subject metadata (search across characteristics of the study, subject, and sample), due to the scale of the sequence data (with between 3000 and 13 000 000 sequences/sample) it was not possible to interactively explore the sequence and sequence annotation data in iReceptor v1.0.
With the focus of iReceptor on sharing of data, it is critical that we do not overlook the fact that AIRR-seq data are often human health data, and therefore data security and data provenance need to be considered. Recall from above that one of the key benefits of a distributed data model is that a local data repository allows a data steward to store, monitor, and share data in accordance with the associated ethics and sharing agreements. Although only implemented at a very basic level, the iReceptor Repository Service and iReceptor API provide a security layer that can either be turned on (for repositories that require security) or off (for repositories that provide open access to public data). It is the responsibility of the data steward operating the repository to ensure that the data in the repository are protected with the correct level of data security according to the study's ethics and sharing constraints.
The iReceptor v1.0 security layer relies on a trust relationship between the iReceptor Repository Service and the iReceptor Gateway.
When a Repository Service registers with the iReceptor Gateway, it provides a shared secret to the Gateway (a password for authentication to the service). The Repository Service allows access to the repository based on user-level authorization. On every connection to the Repository Service, the Gateway provides the Repository Service with the shared secret and the Gateway user name of the user requesting access. The Repository Service authenticates the Gateway using the shared secret, ensuring the client is trusted. Once authenticated, the service then maps the gateway user requesting access to a local user and determines if that user is authorized to access the repository. If so, the Repository Service responds to the request. If not, the service responds with an unauthorized access response. All data are communicated over an SSL encrypted communication channel.
It is important to point out the limitations of this security model.
The only authentication that occurs is between the iReceptor
Gateway and the iReceptor Repository Service. This establishes the trust relationship. The iReceptor Repository Service must manage the mapping of iReceptor Gateway users to users who are authorized to access the local repository. There is currently no locally supported authentication at the repository level, requiring the repository to trust that when the Gateway says that John Doe wants access that the Gateway is really requesting that access on behalf of John Doe. In addition, there is currently no fine-grained authorization providing different levels of user access to different parts of the repository. Although these are on the current roadmap for implementation within the iReceptor framework, only the authentication and authorization described above are currently supported.
Although one of the deliverables of the iReceptor v1.0 proposal was to provide the ability for research groups to download and install the software that implemented the iReceptor data repository (MySQL data model), the iReceptor Repository Service, and the iReceptor REST API, it was recognized early in development that many research groups will have invested in their own data repository technologies and their own data collections. In these instances, it is not practical for such a laboratory to change repository technologies.
Instead, the iReceptor model provides a mechanism for a laboratory with an existing repository to join the iReceptor AIRR-seq network.
For a repository to "join" the iReceptor AIRR-seq network, the repository owner needs to (i) translate their internal data representation of the repository into the iReceptor standard metadata fields,
(ii) provide an implementation of a data service that implements the iReceptor API queries, and (iii) return the iReceptor data fields in an iReceptor API compliant format. form that allows users to upload and process AIRR-seq data using a range of analysis pipelines. As part of iReceptor v1.0, the iReceptor and VDJServer teams developed an iReceptor Repository
Service that acted as a proxy for the VDJServer repository and produced iReceptor API compliant data. In this fashion, the iReceptor Gateway was able to not only query the three iReceptor repositories but was also able to query the VDJServer repository iReceptor has made extensive use of the MiAIRR standardization efforts to direct its development.
1.
The iReceptor data curation methodology that is used to load data into the iReceptor Public Archive (IPA) has been extended to include the use of MiAIRR terms. Although the iReceptor data curators have little control over the data that authors publish, when loading data into IPA any MiAIRR compliant data that are available from a paper are included in the repository.
2.
All iReceptor repositories have been extended to be able to include all MiAIRR data fields. If a study includes a MiAIRR field then the iReceptor repositories will be able to store it. One of the key challenges of any data repository is to be able to perform searches on the data in the repository as the repository grows. iReceptor and its Scientific Gateway support two types of data repository operations:
1. Synchronous operations are those that can be performed on a data repository in "user interactive" time frames. By "user interactive" we mean time frames that a user would be willing to wait in front of a computer screen to get a response, ie, 
Asynchronous operations are operations that require longer than 2 minutes to perform. Asynchronous operations are typically either operations where the user wants to perform a complex query at the sequence level and/or perform some sort of detailed analysis applied to a federated data set. Asynchronous operations can take minutes to days to complete and are managed as "jobs". In these cases, the iReceptor Gateway manages federating data from the repositories, staging those data to a computational resource, running the analysis application, staging the results back to the gateway, and notifying the user when the analysis is complete using the Science-as-a-Service AGAVE platform. In iReceptor v1.0, we utilized MySQL as our repository technology. As we explored the types of interactive queries that we wanted to perform with our user community, we rapidly realized that MySQL would not scale to the level that we desired. Over the past year, the iReceptor team has been exploring the use of MongoDB 45 In addition, it is important to note that once we find a limit to MongoDB's scalability for AIRR-seq data, as we inevitably will, the distributed data model on which iReceptor is built makes it simple to add another repository (or indeed many more repositories) of the same scale. This gives iReceptor the ability to both "scale up" a single repository as well as "scale out" to multiple large and/or many small repositories as required.
To facilitate the uptake in sharing AIRR-seq data, iReceptor has built on its knowledge of using MongoDB for AIRR-seq data, to create what we call the iReceptor Turnkey Repository. The iReceptor Turnkey Repository is an easy to install package that enables research laboratories to install and manage their own iReceptor compliant repositories. The Turnkey platform includes an iReceptor MongoDB Repository (with appropriate indexes on critical fields), an iReceptor Repository Service, and a data import pipeline for MiAIRR metadata and V-, D-, and J-gene annotation from a variety of tools, including IMGT VQuest, 46 igBlast, 47 and MiXCR.
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The iReceptor Turnkey Repository is available for download from GitHub. 48 Last, but certainly not least, we recognize that many laboratories • The VDJServer Repository (Dallas, Texas): The VDJServer public data repository, with approximately 70M sequences from multiples studies and laboratories. We anticipate the VDJServer repository will grow to billions of sequences.
As the AIRR Community converges on a definition of an AIRR Data
Commons, we anticipate convergence of the iReceptor and AIRR Data
Commons. This will result in all iReceptor repositories being compliant with, and participating in, the AIRR Data Commons. We anticipate that the AIRR Data Commons will soon consist of 10s, if not 100s, of repositories that span the scales listed above. Components that will be impacted by the evolution of the AIRR Community and its standards are as follows:
• The iReceptor repositories, in particular the iReceptor Public
Archive and the iReceptor Turnkey Archive, will evolve to meet as-a-Service capabilities, 44 there has been little work on integrating advanced analysis applications into the iReceptor Scientific Gateway to date. Given that both VDJServer and iReceptor make use of AGAVE as a middleware platform, it is anticipated that we will be able to leverage each other's work in this area. VDJServer's current capabilities in terms of providing analysis pipelines 39, 40 is far more advanced than iReceptor's, but it is anticipated that our ongoing collaboration will result in shared developments around integrating these analysis tools on federated AIRR-seq data.
| IRECEP TOR US E C A S E S
As previously stated, the primary purpose of the iReceptor resource is to lower the barrier for researchers to share, reuse, explore, and analyze AIRR-seq data to answer questions about immunogenetics and the immune response. The usefulness of the iReceptor platform is highlighted by the following two simple use cases. Use Case 1 demonstrates a search for partial CDR3 sequences across datasets from different laboratories and repositories. Use Case 2 demonstrates the interactive search of sample metadata across different repositories to identify candidate AIRR-seq data sets whose analysis might help validate a research hypothesis. Interviews with iReceptor users and general discussions within the AIRR Community suggest that these two types of searches, one searching for a specific sequence and one over metadata, will encompass most of the searches that researchers will perform on iReceptor and other AIRR-seq resources.
| Use Case 1-looking for a needle in a haystack!
The CDR3 region is the most diverse part of the full adaptive immune receptor gene. Given this diversity, we would not expect to find common CDR3 sequences among unrelated individuals.
However, specific B-cell and T-cell receptors are found in multiple individuals for various immune responses, and are referred to as public clonotypes. 49 The role of these public BCRs and TCRs in human health is still being studied, but one role would be fighting 
| The challenge
This use case in some ways presents a worst-case scenario for any data repository. It is essentially searching for an entity at the finest granularity of detail (the needle-in this case an annotated sequence feature such as a partial CDR3 sequence) across the entire data set (the haystack-in the distributed repository case a search across all data in all repositories). It is a brute force search without any data refinement or data reduction before the detailed search takes place.
In a world in which there were no AIRR-seq data commons, individual researchers and laboratories would store their own processed data, associated metadata, and in some cases (but not all) publications uploaded to central repositories like GenBank and SRA. In this case, performing the above search would be extremely labor intensive and time consuming, with a researcher having to perform the following steps:
1. Finding: Identify a set of papers and/or laboratories that would have relevant study data.
2.
Federating: Find the appropriate data sets from those studies and downloading them to local storage.
3.
Curating: Reconstruct the appropriate MiAIRR compliant metadata from those studies so the downloaded data can be compared. If studies do not archive the metadata required for comparisons with the sequence data, it would be necessary to reconstruct the metadata from the text of the papers.
4.
Annotating: If a study has open, published data, they are most likely to be the "raw" sequence data (FASTA files) without the sequence annotations (eg, without V-, D-, and J-gene and CDR3 identification). In these cases, it is necessary to reproduce the annotation pipeline used in the paper and/or develop your own annotation pipeline to process the "raw" sequence data to attain the gene and CDR3 sequence annotation.
5.
Analyzing: Search the annotated sequences for the CDR3 sequence feature of interest.
It is easy to see why such a process is challenging and often beyond the resources of many research groups.
Within the iReceptor Data Commons, this process becomes relatively straightforward:
1. Finding: Data repositories with MiAIRR compliant data are registered with the Data Commons.
Federating: The iReceptor Scientific Gateway performs queries
across the federated repositories on behalf of the user as well as federating the results of the queries into a single manageable data set.
3.
Curating: Data in the repositories are MiAIRR compliant to the degree that they can be, and therefore no curation is required during the exploration process. This does not mean that curation does not need to happen, but the curation happens only once when the data are added to a repository.
4.
Annotating: Curated MiAIRR data are annotated as part of the curation process.
5.
Analyzing: The iReceptor Scientific Gateway can perform simple analyses such as searching for a specific gene annotation or a CDR3 sequence interactively, while more complex analyses can be managed through asynchronous jobs.
The iReceptor Data Commons (and indeed any data commons) puts a much larger burden on the curation process, but once curated these data can be shared seamlessly for the broad AIRR-seq research community to answer a wide range of research questions.
| Using iReceptor to find the needle!
Using the iReceptor Scientific Gateway in Use Case 1 is quite simple.
The researcher would: This also allows the researcher to identify the study and contact the researcher who generated the data set if other information is necessary about the data or study (Figure 3 ).
| Use Case 1 results
In Use Case 1, we compared results from a study on EBV-specific public TCR clonotypes found in 3 healthy patients and 3 lung trans- Table 1 ) from the IPA resource curated by the iReceptor team, and the repository curated
by VDJServer. Table 2 shows the number of times these motifs were observed among the 117 samples sequenced from these 35 individuals (only 40 of the 63 motifs were observed in the repertoires from these new individuals and are listed in Table 2 ). Some of these motifs were very common in the new data sets, with one of them found in 44 of the 117 samples. Table 2 
| The challenge
In this use case, the challenges are less about scale (eg, number of samples) and more about the richness of the data supporting the comparisons that the researcher wants to explore. All the challenges from the Use Case 1 still apply, but the challenge around data curation, data comparison, and data analysis is paramount for Use Case 2.
Whenever it is necessary to find and compare data with different characteristics, the quality of the metadata that describes those characteristics is critical. That is, we want to partition all the data across all the distributed repositories (our haystack) into subsets 
| Using iReceptor to find (and analyze) the needles
The search performed in Use Case 2 is much more complex than Use Case 1. In this analysis, the researcher is starting with an exploratory analysis, looking for studies that might be relevant to their research question around heredity and CDR3 diversity. Using the iReceptor Scientific Gateway to perform this exploratory analysis is relatively easy-the researcher would:
1. Log in to the iReceptor Scientific Gateway
Perform a metadata search looking for studies of interest
As a start, the most promising search criteria would be to search for keywords such as "heredity", "child", "parent", "mother", "father", and "twin" in fields where you would expect these keywords to be used (eg, Study Title). Performing such a search on the iReceptor Scientific Gateway performs a query across all repositories in the iReceptor Data Commons and discovers two studies of relevance.
Both the keyword "mother" and "child" discover a deep profiling study on mother and child T-Cell repertoires by Putintseva et al. 49 This study compared the V-segment usage and the relative overlap of CDR3-sequence features between TCR repertoires of mother and children for which the child siblings were non-twins. The iReceptor Gateway provides access to the metadata for this study, including the fact that it consists of samples from 3 mothers and 3 pairs of siblings (1 per mother) for a total of 9 biological samples. The overall study consists of over 55 million annotated sequences and was found in the iReceptor Public Archive repository. The iReceptor Gateway links back to other relevant resources for this study, such as its NCBI BioProject information.
Searching for the keyword "twin" also finds a relevant study of the repertoires from 5 pairs of monozygotic twins. 51 In this study, Eventually, it is likely that a federated data analysis step would need to be carried out on these data to assess, for example, CDR3 diversity across the two data sets. Such an analysis is beyond the scope of the interactive explorations provided by the iReceptor Scientific Gateway's web portal. Although at the current time the iReceptor Gateway supports the management of asynchronous (long running) analyses, it does not have a significant number of analysis applications integrated into the platform (recall that this is on the iReceptor v3.0 roadmap). As a result, it is necessary for a researcher to download the federated data and perform such an analysis offline.
Fortunately, the iReceptor Gateway can still be of assistance, as it is possible for the researcher to request the download of both data sets from each repository in a single consistent file format that makes comparative analyses straightforward. The iReceptor Scientific Gateway uses the AIRR Community's emerging AIRR TSV file format as its data interchange format. As a result, the annotated data from both the Rubelt et al and the Putintseva et al studies can be downloaded by the researcher in a format that makes comparative analyses relatively straightforward.
To demonstrate iReceptor's functionality, the comparative analysis for Use Case 2 was performed as an offline analysis once the federated data were downloaded from the iReceptor Gateway. 
| Use Case 2 results
When using monozygotic twin pairs to estimate the effect of heredity on any phenotype the most critical comparison is similarity between monozygotic twins compared to related sibling pairs. The expectation is that monozygotic twins, by having the same genotype, will exhibit higher similarity compared to non-monozygotic siblings. We explored this expectation by comparing monozygotic twin pairs from Rubelt et al and siblings from the Putintseva et al studies.
At first we were surprised that there was not a strong difference between these types of pairs, for various measures of overlap between repertoires. The amount of data per repertoire was very different, with the read depth from Putintseva et al ranging from 17 000 to 66 000 sequences, while read depths per repertoire in Rubelt et al were typically several million. We attempted to adjust for these differences, but finally resorted to randomly drawing 50 000 reads per sample from the Rubelt et al study to make read depths similar between studies.
Repertoire overlap for these pairs of individuals is presented in Table 3 . In this case, overlap was calculated as follows. First the unique CDR3 sequences were determined for each member of a pair, say A and B, and the set of shared CDR3 sequences was determined.
Then the number of sequence reads for individual A that matched any of the shared sequences, divided by the total reads in the repertoire of A, is the repertoire overlap with A as the reference repertoire and B as the target repertoire (reported in Table 3 ). As shown explicitly in Table 3 , the average for 5 pairs of monozygotic twins from Rubelt et al was compared to the average overlap for 3 pairs of full sibling pairs from Putintseva et al. The average overlap for all monozygotic twins was 6.31, which was not much higher than the average value of 4.81 for full sibling pairs. This result could be confounded by differences between these studies, such as sequencing methods and ethnicity of sampled individuals. These differences are potential problems when combining data from multiple studies. Even so, this comparison shows a surprising result, which could motivate more controlled comparisons. This data exploration potential is one of the strengths of the data commons approach, as exemplified by iReceptor, and this will only be stronger when the data commons includes more repositories to be mined and more controlled descriptions of the metadata associated with each study in the set of repositories to facilitate better matched comparisons. 
| INVITATI ON TO PARTICIPATE IN IRECEP TOR NE T WORK AND AIRR COMMUNIT Y INITIATIVE
The AIRR Community has worked since 2015 to encourage sharing of AIRR-seq data, with the goal of improving biomedical research and patient care. The success of such initiatives depends on openness and community spirit, to which the community has been dedicated.
Please see airr-community.org or contact join@airr-community.org to join this growing group of researchers.
The iReceptor team is dedicated to implementing our vision of the AIRR Community's Data Commons (gateway.ireceptor.org).
Please contact us at support@ireceptor.org to see how your laboratory can become a member of this growing network. 
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